Krahasoni metodat

	Inventari i Ankthit Geriatrik	Intervista Telefonike për Statusin Konjitiv
Fusha	Gerontologji	Gerontologji
Familja	Process / pipeline	Process / pipeline
Viti i origjinës	2007	1988
Krijuesi	Nancy A. Pachana	J.C. Breitner
Lloji	Self-report questionnaire	Telephone-administered cognitive interview
Burimi themelues	Pachana, N. A., Byrne, G. J., Looi, J. C., Krishnan, V., & Hilbert, M. M. (2007). Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr, 19(1), 103-114.	Breitner, J. C., Folstein, M. F., & Murphy, E. A. (1989). Familial aggregation in Alzheimer dementia: comparison of risk estimates. Genet Epidemiol, 6(1), 35-45.
Emërtime të tjera	GAI	TICS, TICS-m, Modified Telephone Interview for Cognitive Status
Të lidhura	5	5
Përmbledhja	The Geriatric Anxiety Inventory (GAI) is a 20-item self-report questionnaire developed by Pachana and colleagues in 2007 to assess anxiety symptoms specifically in older adults. Designed to address the limitations of general anxiety scales in detecting anxiety in older populations—where anxiety may present atypically or be masked by somatic complaints and medical comorbidities—the GAI focuses on cognitive and affective symptoms of anxiety with minimal emphasis on physical symptoms. It is widely used in geriatric practice, mental health clinics, and research to screen for and evaluate anxiety disorders in seniors.	The Telephone Interview for Cognitive Status (TICS) is a telephone-administered cognitive screening instrument developed by Breitner and colleagues in the late 1980s and modified (TICS-m) to assess cognitive function in older adults via remote interview. Designed for epidemiological studies and clinical research where in-person assessment is impractical or resource-intensive, the TICS combines questions assessing orientation, attention, language, memory, and reasoning in a format suitable for administration by trained interviewers without specialized clinical equipment. It has become widely used in longitudinal cohort studies, clinical trials, and telemedicine settings for cognitive screening and monitoring.